+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Blood Transfusion Diagnostics - Global Market Outlook (2019-2027)

  • ID: 5157683
  • Report
  • August 2020
  • Region: Global
  • 194 pages
  • Stratistics Market Research Consulting Pvt Ltd
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Diagnostics
  • Beckman Coulter
  • Bio-Rad Laboratories
  • DiaSorin
  • Grifols
  • Novartis
  • MORE
According to the report, the Global blood Transfusion Diagnostics Market accounted for $4.0 billion in 2019 and is expected to reach $7.56 billion by 2027, growing at a CAGR of 8.3% during the forecast period.

Some of the key factors propelling the market growth are increasing prevalence of chronic diseases, rising number of surgical procedures, and growing initiatives for blood donation campaigns. However, the lack of skilled professionals is the restraining factor for the growth of the market.

Blood transfusion is the method of transferring blood or blood products from one person to another. It is adopted during various medical conditions such as loss of blood or any other components of the blood. Blood transfusion diagnostics play a crucial role in blood transfusion to avoid infection to both the receiver and donor.

By end-user, the blood banks segment is expected to grow at a significant market share during the forecast period as several disease screening and blood typing services need to be performed before a transfusion therapy. Based on geography, North America is anticipated to hold considerable market share during the forecast period owing to the presence of major companies and increasing awareness among people regarding blood donations.

Some of the key players in blood Transfusion Diagnostics Market include Siemens Healthineers, Thermo Fisher Scientific, Abbott Diagnostics, Roche Diagnostics, becton, Dickinson and Company, bio-Rad Laboratories, beckman Coulter, Novartis, Grifols, Ortho Clinical Diagnostics, Fujirebio, bioMerieux, DiaSorin, Immucor, Diagast, bAG healthcare, and Quidel.

Products Covered:
  • Instruments
  • Reagents & Kits
Blood Products Covered:
  • Red blood Cells (RBC)
  • Albumin
  • Plasma
  • Platelets
  • Immunoglobulin Preparations
Technologies Covered:
  • Western blot
  • Fluorescence Assay
  • Rapid Test
  • Nucleic Acid Amplification
  • Enzyme-Linked Immunosorbent Assay (ELISA)
Applications Covered:
  • Blood Grouping
  • Disease Screening
End-users Covered:
  • Hospitals
  • Clinics
  • Plasma Fractionation Companies
  • Blood banks
  • Diagnostic Laboratories
Regions Covered:

North America
  • US
  • Canada
  • Mexico
Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia-Pacific
South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What the report offers:
  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
Free Customization Offerings

Purchasers of this report will be entitled to receive one of the following free customization options:

1. Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
2. Regional Segmentation
  • Market estimations, forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
3. Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Beckman Coulter
  • Bio-Rad Laboratories
  • DiaSorin
  • Grifols
  • Novartis
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End-user Analysis
3.10 Emerging Markets
3.11 Impact of COVID-19

4 Porters Five Forces Analysis
4.1 Bargaining Power of Suppliers
4.2 Bargaining Power of Buyers
4.3 Threat of Substitutes
4.4 Threat of New Entrants
4.5 Competitive Rivalry

5 Global Blood Transfusion Diagnostics Market, By Product
5.1 Introduction
5.2 Instruments
5.3 Reagents & Kits

6 Global Blood Transfusion Diagnostics Market, By Blood Product
6.1 Introduction
6.2 Red Blood Cells (RBC)
6.3 Albumin
6.4 Plasma
6.5 Platelets
6.6 Immunoglobulin Preparations

7 Global Blood Transfusion Diagnostics Market, By Technology
7.1 Introduction
7.2 Western Blot
7.3 Fluorescence Assay
7.4 Rapid Test
7.5 Nucleic Acid Amplification
7.5.1 Real-Time Polymerase Chain Reaction (PCR)
7.5.2 Thermomechanical Analysis (TMA)
7.6 Enzyme-Linked Immunosorbent Assay (ELISA)
7.6.1 Chemiluminescence Immunoassay (CLIA)
7.6.2 Colorimetric Immunoassay (CI)
7.6.3 Fluorescence Immunoassays (FIA)

8 Global Blood Transfusion Diagnostics Market, By Application
8.1 Introduction
8.2 Blood Grouping
8.3 Disease Screening
8.3.1 Molecular Disease Screening
8.3.2 Serological Disease Screening

9 Global Blood Transfusion Diagnostics Market, By End-user
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Plasma Fractionation Companies
9.5 Blood Banks
9.6 Diagnostic Laboratories

10 Global Blood Transfusion Diagnostics Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia-Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launches
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Siemens Healthineers
12.2 Thermo Fisher Scientific
12.3 Abbott Diagnostics
12.4 Roche Diagnostics
12.5 Becton, Dickinson and Company
12.6 Bio-Rad Laboratories
12.7 Beckman Coulter
12.8 Novartis
12.9 Grifols
12.10 Ortho Clinical Diagnostics
12.11 Fujirebio
12.12 BioMerieux
12.13 DiaSorin
12.14 Immucor
12.15 Diagast
12.16 BAG Healthcare
12.17 Quidel

List of Tables
Table 1 Global Blood Transfusion Diagnostics Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Blood Transfusion Diagnostics Market Outlook, By Product (2018-2027) ($MN)
Table 3 Global Blood Transfusion Diagnostics Market Outlook, By Instruments (2018-2027) ($MN)
Table 4 Global Blood Transfusion Diagnostics Market Outlook, By Reagents & Kits (2018-2027) ($MN)
Table 5 Global Blood Transfusion Diagnostics Market Outlook, By Blood Product (2018-2027) ($MN)
Table 6 Global Blood Transfusion Diagnostics Market Outlook, By Red Blood Cells (RBC) (2018-2027) ($MN)
Table 7 Global Blood Transfusion Diagnostics Market Outlook, By Albumin (2018-2027) ($MN)
Table 8 Global Blood Transfusion Diagnostics Market Outlook, By Plasma (2018-2027) ($MN)
Table 9 Global Blood Transfusion Diagnostics Market Outlook, By Platelets (2018-2027) ($MN)
Table 10 Global Blood Transfusion Diagnostics Market Outlook, By Immunoglobulin Preparations (2018-2027) ($MN)
Table 11 Global Blood Transfusion Diagnostics Market Outlook, By Technology (2018-2027) ($MN)
Table 12 Global Blood Transfusion Diagnostics Market Outlook, By Western Blot (2018-2027) ($MN)
Table 13 Global Blood Transfusion Diagnostics Market Outlook, By Fluorescence Assay (2018-2027) ($MN)
Table 14 Global Blood Transfusion Diagnostics Market Outlook, By Rapid Test (2018-2027) ($MN)
Table 15 Global Blood Transfusion Diagnostics Market Outlook, By Nucleic Acid Amplification (2018-2027) ($MN)
Table 16 Global Blood Transfusion Diagnostics Market Outlook, By Real-Time Polymerase Chain Reaction (PCR) (2018-2027) ($MN)
Table 17 Global Blood Transfusion Diagnostics Market Outlook, By Thermomechanical Analysis (TMA) (2018-2027) ($MN)
Table 18 Global Blood Transfusion Diagnostics Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2018-2027) ($MN)
Table 19 Global Blood Transfusion Diagnostics Market Outlook, By Chemiluminescence Immunoassay (CLIA) (2018-2027) ($MN)
Table 20 Global Blood Transfusion Diagnostics Market Outlook, By Colorimetric Immunoassay (CI) (2018-2027) ($MN)
Table 21 Global Blood Transfusion Diagnostics Market Outlook, By Fluorescence Immunoassays (FIA) (2018-2027) ($MN)
Table 22 Global Blood Transfusion Diagnostics Market Outlook, By Application (2018-2027) ($MN)
Table 23 Global Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2018-2027) ($MN)
Table 24 Global Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2018-2027) ($MN)
Table 25 Global Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2018-2027) ($MN)
Table 26 Global Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2018-2027) ($MN)
Table 27 Global Blood Transfusion Diagnostics Market Outlook, By End-user (2018-2027) ($MN)
Table 28 Global Blood Transfusion Diagnostics Market Outlook, By Hospitals (2018-2027) ($MN)
Table 29 Global Blood Transfusion Diagnostics Market Outlook, By Clinics (2018-2027) ($MN)
Table 30 Global Blood Transfusion Diagnostics Market Outlook, By Plasma Fractionation Companies (2018-2027) ($MN)
Table 31 Global Blood Transfusion Diagnostics Market Outlook, By Blood Banks (2018-2027) ($MN)
Table 32 Global Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2018-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above
Note: Product cover images may vary from those shown
3 of 4
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Abbott Diagnostics
  • Roche Diagnostics
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Beckman Coulter
  • Novartis
  • Grifols
  • Ortho Clinical Diagnostics
  • Fujirebio
  • BioMerieux
  • DiaSorin
  • Immucor
  • Diagast
  • BAG Healthcare
  • Quidel
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll